Under the theme of personalized medicine, in vitro diagnostics will play an increasingly important role in new drug entries and new therapies
Gerry McDougall, PriceWaterhouseCoopers
Advertisement
Articles by Gerry McDougall, PriceWaterhouseCoopers
Advertisement
Latest Updated Articles
- The Rise of 'Companion' Diagnostics for Specialty Pharmaceuticals
October 11th 2009
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
When Drug Pricing Collides With Politics
2
The End of the Traditional Launch: How JCA, HTA Evolution and Pricing Pressures Are Driving Continuous Evidence Generation
3
How CMS’ Final Negotiation Rule Treats New Drug Formulations
4
Idle US Capacity Could Anchor Generic Drug Reshoring, APIIC Says
5